Skip to main content
Glama

EVEE MCP 서버

EVEE (Evo Variant Effect Explorer) API를 위한 MCP 서버 — Evo 2 유전체 파운데이션 모델 임베딩을 기반으로 한 해석 가능한 변이 효과 예측을 제공합니다.

EVEE는 420만 개의 ClinVar 변이에 대해 사전 계산된 병원성 예측, 파괴 프로필 및 AI가 생성한 기계론적 해석을 제공합니다. 전체 논문은 Pearce et al. (2026)을 참조하십시오.

도구

도구

설명

search_variants

유전자 기호, rsID 또는 ClinVar 변이 ID에 대한 자동 완성 스타일 조회(최대 6개 일치 항목); 후보 변이 ID를 찾는 데 유용하며, 유전자 전체 순위를 매기는 용도는 아님

get_variant

임상 요약, EVEE 파생 효과 출력, 데이터베이스 비교 점수(존재 시), AI 생성 기계론적 해석(저장되지 않은 경우 요청 시 자동 생성 트리거)

wait_for_variant_analysis

EVEE의 요청 시 해석 생성이 완료되거나 시간 초과될 때까지 폴링

compare_variants

나란히 비교 요약(한 번의 호출로 최대 10개 변이) — 임상 라벨, 병원성, 상위 1개 파괴, HGVS, 딥 링크

get_variant_disruptions

규모별로 순위가 매겨진 상위 생물학적 주석 파괴(선택적으로 카테고리별 범위 지정 가능) — 변이가 병원성 또는 양성으로 예측되는 이유를 설명

get_variant_annotations

전체 주석 프로브 값(13개 카테고리에 걸친 325개 주석, 선택적으로 카테고리별 필터링 가능)

주석 카테고리

amino_acid, atacseq, ccre, chipseq, chromhmm, elm, fstack, protein_feature, interpro, genomic_feature, ptm, region, secondary_structure

Related MCP server: Evo2 MCP Server

기술

Claude Code 기술은 .claude/skills/evee/SKILL.md에 있습니다. 이를 로드하는 에이전트는 도구를 효과적으로 사용하는 방법(워크플로우 단계, 변이 클래스별 신뢰성 주의 사항, 주의점(0 기반 좌표, indel VCF 앵커링, 대소문자 구분 등))에 대한 약 120줄의 지침을 받습니다.

사용법

Python 3.10+ 및 uv가 필요합니다.

git clone git@github.com:goodfire-ai/evee-mcp.git
cd evee-mcp
uv sync

Claude Code

저장소는 .mcp.json을 제공합니다. 디렉토리를 열면 권한 프롬프트가 트리거됩니다:

claude

Claude Desktop

claude_desktop_config.json에 추가하십시오:

{
  "mcpServers": {
    "evee": {
      "command": "uv",
      "args": ["run", "--directory", "/absolute/path/to/evee-mcp", "python3", "server.py"]
    }
  }
}

예시

FBN1 변이 rs1597537935는 병원성이 있나요? 있다면 그 이유는 무엇인가요?

에이전트가 검색을 수행하고, AI가 생성한 기계론적 해석이 포함된 임상 요약을 가져오며, 상위 파괴 증거를 추출합니다.

Available Tools

6 tools
compare_variantsA

Compare multiple variants side-by-side.

Fetches clinical label, pathogenicity score, gene, HGVS protein, consequence, and the top-1 disruption for each. Use when the user asks to contrast, rank, or compare 2+ variants, instead of looping get_variant.

Args: variant_ids: List of variant IDs in chr:pos:ref:alt format (max 10).

ParametersJSON Schema
NameRequiredDescriptionDefault
variant_idsYes

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description discloses what data is fetched (clinical label, pathogenicity score, etc.) and the maximum number of variants (10). No annotations provided, so description carries full burden and does so well.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is concise, starts with purpose, then lists fetched fields and parameter details in bullet format. Every sentence adds value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The description is complete for a comparison tool with one parameter and no output schema. Could mention the output structure (e.g., a table or list) but not necessary.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 0%, but the description explains the variant_ids parameter format ('chr:pos:ref:alt') and limit (max 10), adding significant meaning beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool compares variants side-by-side and lists the fetched fields. It differentiates from sibling 'get_variant' by explicitly saying to use instead of looping.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says when to use (contrast, rank, compare 2+ variants) and when not (instead of looping get_variant), providing clear guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

get_variantA

Get comprehensive information about a specific genetic variant.

Returns clinical significance, model-derived scores from EVEE's heads (aligned to AlphaMissense, CADD, REVEL, SIFT, etc.), reference predictor scores from external databases when present, gene constraint (LOEUF), HGVS notation, disease associations, protein domains, and the AI-generated mechanistic interpretation.

If the stored interpretation isn't ready, this tool hits EVEE's on-demand /analysis endpoint once: if generation has already completed, the fresh interpretation is returned inline; otherwise the response carries an interpretation = {status: queued/processing, detail: ...} entry and you should call wait_for_variant_analysis to poll until it finishes.

Args: variant_id: Variant identifier in chr:pos:ref:alt format (e.g. "chr17:43092918:G:A" for BRCA1 ClinVar ID 41812). NOTE: EVEE uses 0-based positions; ClinVar/VCF/HGVS are 1-based. Subtract 1 from ClinVar pos for SNVs; for indels the offset varies — prefer search_variants.

ParametersJSON Schema
NameRequiredDescriptionDefault
variant_idYes

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With no annotations, the description fully discloses behavior: hitting an on-demand endpoint, returning status if analysis not ready, and suggesting polling. Also explains coordinate system differences, which is critical for correct usage.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is well-structured and front-loaded, but slightly verbose with some long sentences. However, all content is necessary given the tool's complexity, earning its space.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description covers all essential aspects: return values, conditional behavior, input format, and edge cases. It is complete and preempts common questions.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 0%, but the description provides extensive details: format (chr:pos:ref:alt), example, and a crucial note about 0-based vs 1-based positions. This adds significant meaning beyond the simple string type.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool gets comprehensive information about a genetic variant and lists specific attributes. It distinguishes from siblings by mentioning wait_for_variant_analysis and search_variants for alternative use cases.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says when to use this tool and when to use alternatives: if interpretation is queued, call wait_for_variant_analysis; for indels, prefer search_variants. Provides clear context for decision-making.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

get_variant_annotationsA

Get detailed annotation probe values for a variant.

Returns the Evo 2 model's predicted annotation values for both the reference and alternate allele across 325 biological annotations. Each annotation shows ref (reference allele prediction), alt (alternate allele prediction), and delta (alt - ref).

Use this for deep analysis when you need the full picture — e.g., all chromatin marks across tissues, all amino acid probabilities, or every protein feature prediction. For a quick ranked view of what's most disrupted, use get_variant_disruptions instead.

Args: variant_id: Variant identifier in chr:pos:ref:alt format. category: Optional filter. One of: amino_acid, atacseq, ccre, chipseq, chromhmm, elm, fstack, protein_feature, interpro, genomic_feature, ptm, region, secondary_structure. Omit to get ALL annotations.

ParametersJSON Schema
NameRequiredDescriptionDefault
variant_idYes
categoryNo

TDQS

A4.8/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations, but description fully explains output structure (ref, alt, delta per annotation) and parameter details. No mention of side effects or auth, but read-only nature is implicit.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Well-structured with clear paragraphs, bullet-like list for categories, and no redundant sentences. Efficiently conveys all necessary information.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Covers both parameters, explains return structure (325 annotations with ref/alt/delta), provides category filter details, and references sibling tool. Complete for a read-only query tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 0%, but description adds valuable semantics: variant_id format (chr:pos:ref:alt) and lists category options with example values, compensating fully.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states it gets 'detailed annotation probe values for a variant', specifies ref, alt, delta fields, and distinguishes from sibling get_variant_disruptions which offers quick ranked view.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'use this for deep analysis' and advises to use get_variant_disruptions for quick ranked view, providing clear when-to-use and alternative.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

get_variant_disruptionsA

Get the top biological annotation disruptions for a variant.

Shows which molecular features are most affected by the variant, ranked by magnitude of change. Each disruption shows what the Evo 2 model predicts for the reference vs. alternate allele across 325 biological annotations spanning protein structure, chromatin state, regulatory elements, splice sites, and more.

This is the key tool for understanding WHY a variant is predicted pathogenic or benign — e.g., a splice-site variant might show large disruptions in splice donor/acceptor annotations, while a missense variant might show disruptions in protein domain and secondary structure annotations.

Categories: amino_acid, atacseq, ccre, chipseq, chromhmm, elm, fstack, protein_feature, interpro, genomic_feature, ptm, region, secondary_structure.

Args: variant_id: Variant identifier in chr:pos:ref:alt format. top_n: Number of top disruptions to return (default 15, max 100). category: Optional category filter — restrict ranking to one category (e.g. to see only splice-related disruptions: category='genomic_feature').

ParametersJSON Schema
NameRequiredDescriptionDefault
variant_idYes
top_nNo
categoryNo

TDQS

A3.9/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With no annotations, the description carries full burden and does well: discloses it returns ranked disruptions from Evo 2 model across 325 annotations, mentions categories. However, it does not address error behavior (e.g., invalid variant_id) or provide details about output structure, but overall it is transparent about what the tool does.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Well-structured with clear sections: purpose, explanation, categories list, and parameters. Slightly verbose with the categories list and example, but all information is useful. The front-loaded sentence effectively states the action.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

While param descriptions are solid and the output concept is explained, the absence of an output schema means the description should ideally detail the returned fields or format. It only mentions 'shows which molecular features are most affected' which is vague. Could be more complete for a tool that returns structured data.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 0%, but the description fully compensates: specifies variant_id format, top_n default and max, and category filter with an example. This adds essential meaning beyond the bare schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

Clearly states it retrieves top biological annotation disruptions for a variant. The explanation of ranking and categories adds clarity. However, it does not explicitly differentiate from sibling tools like get_variant_annotations, which might also provide disruption info, so purpose is clear but not fully distinguished.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides context that this is the key tool for understanding pathogenicity, and includes example usage with category filter. However, it does not specify when not to use it or compare it directly to sibling tools, leaving some ambiguity about choosing among similar tools.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

search_variantsA

Autocomplete-style variant lookup (up to 6 matches) in the EVEE database.

The query must be ONE of these exact types — do NOT combine them or add extra words like "pathogenic":

  • A gene name: "BRCA1", "TP53", "FBN1"

  • An rsID: "rs1597537935"

  • A ClinVar variation ID (numeric): "655979"

Returns at most 6 autocomplete-style matches. Pagination/limit params are ignored by the backend.

WARNING: a gene-name query returns an adjacent-position autocomplete slice of variants in that gene — NOT the top-pathogenicity variants of the gene. Do not infer the gene's pathogenic landscape from these 6 rows. To look up a specific variant, query by rsID or ClinVar variation ID.

Use this as the starting point to find variant IDs for the other tools.

ParametersJSON Schema
NameRequiredDescriptionDefault
queryYes

Output Schema

ParametersJSON Schema
NameRequiredDescription
resultYes

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With no annotations provided, the description fully discloses behavioral traits: returns at most 6 matches, pagination/limit parameters are ignored, and the nature of gene-name query results (adjacent-position slice, not pathogenic landscape). It also warns about inferring pathogenic landscape from limited rows.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is well-structured with a clear first sentence stating purpose and limit, followed by bullet-like specifics for query types, and warnings. Every sentence adds value without redundancy.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool has an output schema (not shown but indicated), the description does not need to detail return values. It fully covers behavior, limitations, and usage context. For a single-parameter search tool, it is highly complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema provides no description for the single 'query' parameter (0% schema description coverage). The description compensates fully by explaining that the query must be one of three exact types (gene name, rsID, ClinVar variation ID) with examples, and explicitly what not to do.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs 'autocomplete-style variant lookup' in the EVEE database, specifies the exact query types (gene name, rsID, ClinVar ID), and notes it returns up to 6 matches. It distinguishes itself from sibling tools by indicating it is the starting point for finding variant IDs for other tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit when-to-use guidance (starting point for finding variant IDs) and when-not-to (do not combine query types, do not add extra words like 'pathogenic'). It also warns that gene-name queries do not return top-pathogenicity variants and advises using rsID or ClinVar ID for specific variants.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

wait_for_variant_analysisA

Poll EVEE's on-demand interpretation until it completes or times out.

Use this when get_variant reports interpretation.status as queued or processing. Returns the same curated variant summary as get_variant, plus a wait_status entry with attempts / elapsed_seconds. If the deadline hits before completion, call this tool again to keep polling.

Args: variant_id: Variant identifier in chr:pos:ref:alt format. timeout_seconds: Maximum wall-clock time to wait (clamped to [1, 60]). poll_interval_seconds: Delay between polls (clamped to [0.5, 10]).

ParametersJSON Schema
NameRequiredDescriptionDefault
variant_idYes
timeout_secondsNo
poll_interval_secondsNo

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations provided, but the description fully discloses polling behavior, timeout clamping, and return value details (wait_status entry). It is transparent about what happens on deadline hit.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is well-structured with clear sections for purpose, usage, return, and argument details. It is slightly verbose but efficiently uses sentences without redundancy.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a polling tool with no output schema, the description explains the return behavior (same as get_variant plus wait_status), all parameters, and usage context. It is fully self-contained and complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Despite 0% schema description coverage, the description explains each parameter thoroughly: variant_id format, timeout_seconds and poll_interval_seconds with clamping ranges and defaults, adding significant meaning.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description starts with 'Poll EVEE's on-demand interpretation until it completes or times out', providing a specific verb and resource. It clearly distinguishes from sibling tools like get_variant by indicating its polling nature.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly states 'Use this when `get_variant` reports `interpretation.status` as queued or processing', including an alternative scenario. Also notes that if timeout occurs, call again, providing clear guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Tool Schema Changelog

Recent tool additions, removals, and schema changes observed during successful MCP inspections.

  1. 6 tool updatesv0.1.0
    • First observedcompare_variants
    • First observedget_variant
    • First observedget_variant_annotations
    • First observedget_variant_disruptions
    • First observedsearch_variants
    • First observedwait_for_variant_analysis

TDQS

A4.5/5.0

Scored across 6 tools

Disambiguation5/5

Each tool has a clearly distinct purpose: search_variants for lookup, get_variant for comprehensive info, compare_variants for side-by-side comparison, get_variant_annotations for deep probes, get_variant_disruptions for top disruptions, and wait_for_variant_analysis for polling. No overlapping functionality.

Naming Consistency5/5

All tool names follow the verb_noun pattern in snake_case consistently (e.g., compare_variants, get_variant_annotations). The naming is predictable and easy to understand.

Tool Count5/5

With 6 tools, the server covers the core workflows of variant lookup, detailed retrieval, comparison, annotation analysis, disruption ranking, and async waiting. This is well-scoped for a specialized domain without being too few or too many.

Completeness4/5

The tool set covers essential operations: search, retrieve, compare, deep annotations, disruptions, and async polling. A minor gap is the lack of a tool to list all variants for a given gene (search_variants only returns up to 6 autocomplete results), but for targeted variant analysis, the surface is sufficiently complete.

Maintenance

ActivityInactive
ResponsivenessUnresponsive

Related MCP Connectors

Related MCP Servers

  • A
    license
    B
    quality
    D
    maintenance
    Enables AI-powered genomic variant analysis including variant impact prediction, regulatory element discovery, and batch variant scoring. Currently operates in mock mode as a proof-of-concept awaiting the public release of Google DeepMind's AlphaGenome API.
    20
    6 npm
    2
    MIT
  • A
    license
    B
    quality
    D
    maintenance
    Provides a programmatic interface to the Genome Aggregation Database (gnomAD) API across versions v2.1.1, v3.1.2, and v4.1.0. It enables users to query gene metadata, variant information, population frequencies, and ClinVar data through a unified schema.
    12
    6
    Apache 2.0
  • A
    license
    Not graded
    quality
    D
    maintenance
    Enables real-time pharmacogenomics analysis, including variant clinical significance, drug-gene interactions, and dosing guidelines, by connecting to ClinVar, PharmGKB, gnomAD, and other databases.
    1
    MIT